• Anticonvulsants and Chromatin-Genes Expression: A Systems Biology Investigation
• Cancer risk in people with epilepsy: the role of antiepileptic drugs
• Chronic developmental exposure to phenytoin has long-term behavioral consequences
• Embryoprotective role of endogenous catalase in acatalasemic and human catalase-expressing mouse embryos exposed in culture to developmental and phenytoin-enhanced oxidative stress
• Epilepsy and pregnancy
• Fetal Hydantoin Syndrome
• Fetal hydantoin syndrome and its anaesthetic implications: a case report
• Fetal hydantoin syndrome with unilateral atypical cleft hand: additional evidence for vascular disruption
• Fetal hydantoin syndrome: A case report
• Fetal Hydantoin Syndrome: A Case Report
• Impact of phenytoin therapy on the skin and skin disease
• Is Neurofibromatosis Type 1-Noonan Syndrome a Phenotypic Result of Combined Genetic and Epigenetic Factors?
• Monoallelic expression of nine imprinted genes in the sheep embryo occurs after the blastocyst stage
• Neurodevelopmental delay in children exposed to antiepileptic drugs in utero: a critical review directed at structural study-bias
• Neuroendocrine changes in adult female rats prenatally exposed to phenytoin
• Oxidative DNA damage and repair in teratogenesis and neurodevelopmental deficits
• Phenytoin in cutaneous medicine: its uses, mechanisms and side effects
• Phenytoin influence on human metanephros
• Toxic epidermal necrolysis in a mother and fetus
• Transposition of the great arteries and hypocalcemia in a patient with fetal hydantoin syndrome
• Truncus arteriosus in fetal hydantoin syndrome - a new association?